IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0586244
(2017-05-03)
|
등록번호 |
US-9815830
(2017-11-14)
|
발명자
/ 주소 |
- Armer, Thomas
- McKinley, Geoff
- Borland, Scott
- Guzman, Miguel
|
출원인 / 주소 |
- Xoc Pharmaceuticals, Inc.
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
1 인용 특허 :
123 |
초록
▼
Provided herein are isoergoline compounds and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and pharmaceutical compositions disclose
Provided herein are isoergoline compounds and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT1A, 5-HT1B and 5-HT1D receptors without agonizing the 5-HT2B receptor using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing the 5-HT2B adrenergic alpha2A and/or the alpha2B receptors using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing the D2 and D3 receptor using the compounds and pharmaceutical compositions disclosed herein.
대표청구항
▼
1. A compound of structural Formula (IV): or salts thereof, wherein:R1 is independently selected from hydrogen, alkyl, halo, or haloalkyl;R3 is independently selected from hydrogen or alkyl;R4 and R5 are hydrogen or;R4 and R5, together with the atoms to which they are joined form a double bond;R7 is
1. A compound of structural Formula (IV): or salts thereof, wherein:R1 is independently selected from hydrogen, alkyl, halo, or haloalkyl;R3 is independently selected from hydrogen or alkyl;R4 and R5 are hydrogen or;R4 and R5, together with the atoms to which they are joined form a double bond;R7 is R10 is independently selected from alkyl or haloalkyl;b is 1, 2, 3, or 4;Y is —OR12;R12 is independently selected from hydrogen or alkyl;X is —NR8—, andR8 is hydrogen. 2. The compound of claim 1, wherein R3 is methyl. 3. The compound of claim 2, wherein R4 and R5, together with the atoms to which they are joined form a double bond. 4. The compound of claim 3, wherein R1 is hydrogen, CF3, Br, or cyclopropyl. 5. The compound of claim 4, wherein R1 is hydrogen. 6. The compound of claim 4, wherein R1is CF3. 7. The compound of claim 4, wherein R1 is Br. 8. The compound of claim 4, wherein R1 is cyclopropyl. 9. The compound of claims 5, wherein R10 is methyl, b is 1, and R12 is hydrogen. 10. The compound of claim 6, wherein R10 is methyl, b is 1, and R12 is hydrogen. 11. The compound of claim 7, wherein R10 is methyl, b is 1, and R12 is hydrogen. 12. The compound of claim 8, wherein R10 is methyl, b is 1, and R12 is hydrogen. 13. The compound of claim 5, wherein R10 is CH2CF3, b is 1, and R12 is hydrogen. 14. The compound of claims 5, wherein R10 is CF3, b is 1, and R12 is hydrogen. 15. The compound of claim 8, wherein R10 is CF3, b is 1, and R12 is hydrogen.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.